Tenecteplase 40mg Injection

Tenecteplase 40mg is a clot-dissolving medicine used for an acute heart attack with an appropriate ECG pattern. It helps reopen a blocked coronary artery when thrombolysis is selected as the emergency reperfusion treatment.
The reconstituted, weight-adjusted dose is given as a single intravenous bolus over about 10 seconds. Treatment is started as soon as possible within the eligible heart-attack treatment window, with ECG, blood-pressure and bleeding monitoring.
Tenecteplase activates fibrin-associated plasminogen, generating plasmin that breaks down the clot framework.
Bleeding and reperfusion-related rhythm disturbances can occur. Intracranial haemorrhage is the most serious bleeding risk.
Active internal bleeding, a history of haemorrhagic stroke, recent major surgery or trauma, and severe uncontrolled hypertension are important bleeding-risk factors. The 40mg heart-attack presentation must not be treated as a standard stroke dose.
Can restore coronary blood flow and limit heart-muscle damage when given promptly to an eligible patient.
No. The heart-attack dose is selected by body weight; the vial amount is not an automatic individual dose.
No. Symptoms, ECG findings, timing and bleeding risk determine eligibility for thrombolysis.
They reduce renewed clot formation while the blocked coronary artery is being reopened.
An abnormal rhythm can occur when blood flow returns to previously ischaemic heart muscle.
Fibrinolytic: a medicine promoting fibrin breakdown. Coronary artery: an artery supplying the heart muscle. Reperfusion: restoration of blood flow to previously deprived tissue.; AR: Tenecteplase 40mg حقن; FR: Tenecteplase 40mg injection; PT: Tenecteplase 40mg injeção; ES: Tenecteplase 40mg inyección; RU: Tenecteplase 40mg инъекция; ID: Tenecteplase 40mg injeksi; VI: Tenecteplase 40mg thuốc tiêm; MS: Tenecteplase 40mg suntikan; TL: Tenecteplase 40mg iniksyon; ZH-SG: Tenecteplase 40mg 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Tenecteplase 40mg Injection under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Tenecteplase 40mg Injection